Exploiting metabolic vulnerabilities in the detection and treatment of lung cancer

利用代谢脆弱性检测和治疗肺癌

• 批准号: nhmrc : GNT1159002
• 金额: $ 59.17万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/exploiting-metabolic-vulnerabilities-lung-cancer/1379058
• 关键词: Exploiting; metabolic; vulnerabilities; detection; treatment

Lung cancer is a leading cause of cancer-related death in Australia, with new treatment options and early detection a research priority. The proposed project aims to identify lung cancer by-products that can be detected in the patient’s blood, together with the identification of specific therapies tailored to the patient. This will result in a novel combination of lung cancer detection and personalised therapy that will advance current clinical practice through the initiation of clinical trials.

肺癌是澳大利亚癌症相关死亡的主要原因，新的治疗选择和早期发现是研究的重点。拟议项目旨在确定可以在患者血液中检测到的肺癌副产品，以及确定为患者量身定制的特定疗法。这将导致肺癌检测和个性化治疗的新组合，通过临床试验的启动将推进当前的临床实践。